BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2022 9:38:18 AM | Browse: 749 | Download: 1862
 |
Received |
|
2022-01-11 15:34 |
|
Peer-Review Started |
|
2022-01-11 15:35 |
|
First Decision by Editorial Office Director |
|
2022-02-15 00:11 |
|
Return for Revision |
|
2022-02-15 00:11 |
|
Revised |
|
2022-02-27 01:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-06-06 03:23 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-06-17 23:05 |
|
Articles in Press |
|
2022-06-17 23:05 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-01 07:11 |
|
Publish the Manuscript Online |
|
2022-07-22 09:38 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ronald E Cox, Marie Parish, Carolyn Oxencis, Edward Mckenna, Bicky Thapa and Sakti Chakrabarti |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sakti Chakrabarti, MD, Associate Professor, Department of Hematology and Oncology, Medical College of Wisconsin, 8701 W WATERTOWN PLANK RD, Wauwatosa, WI 53222, United States. schakrabarti@mcw.edu |
| Key Words |
COVID-19; Adverse events; Solid tumor; Chemotherapy; Immunotherapy; Targeted therapy |
| Core Tip |
The current study evaluates the safety and spectrum of adverse events associated with coronavirus disease 2019 (COVID-19) vaccination in solid tumor patients receiving systemic therapy. While COVID-19 vaccination has been shown to be safe and effective in the healthy population, the data confirming the safety of COVID-19 vaccines in cancer patients are sparse. The lack of safety data in cancer patients has caused significant hesitancy to receive COVID-19 vaccination among the patient population with cancer. Our study showed that the administration of COVID-19 vaccines in solid tumor patients receiving systemic therapy is safe and should be encouraged. |
| Publish Date |
2022-07-22 09:38 |
| Citation |
Cox RE, Parish M, Oxencis C, Mckenna E, Thapa B, Chakrabarti S. Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy. World J Clin Oncol 2022; 13(7): 599-608 |
| URL |
https://www.wjgnet.com/2218-4333/full/v13/i7/599.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v13.i7.599 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
